Ocata Therapeutics proposes follow-on

Ocata Therapeutics Inc. (OTCBB:OCAT), Marlborough, Mass. Business: Gene/Cell therapy, Ophthalmic Date announced: 2014-12-02 Type: Follow-on To be raised: TBD Shares: 10 million Price prior: $6.21 Unde...